Nipah Virus mRNA Vaccine: NIH Clinical Trial Press Release Shows Another Trial was Launched in July 2022

This is an early-stage clinical trial evaluating an investigational vaccine to prevent infection with Nipah virus. It was manufactured by Moderna in cooperation with NIAID’s Vaccine Research Center

NEWS RELEASES

Monday, July 11, 2022

NIH launches clinical trial of mRNA Nipah virus vaccine

Colorized transmission electron micrograph of mature extracellular Nipah Virus particles (red) near the periphery of an infected VERO cell (green). NIAID

The National Institutes of Health’s National Institute of Allergy and Infectious Diseases (NIAID) is in the news again for another mRNA vaccine trial

This is an early-stage clinical trial evaluating an investigational vaccine to